Although many cells are sensitive to TNF in the presence of the TAK1 kinase inhibitor 5Z-7-oxozeaenol (hereafter referred to as TAK1i), we focused our attention on a cell line that is largely resistant to this treatment combination, namely, the renal cell adenocarcinoma 786-0. The gene discussed is TNF; the disease is renal cell adenocarcinoma.